rac-Erythro-9-(2-hydroxy-3-nonyl)adenine hydrochloride
CAS : 58337-38-5
Ref. 3D-FE16560
| 1mg | Arrêté | ||
| 2mg | Arrêté | ||
| 5mg | Arrêté | ||
| 10mg | Arrêté | ||
| 25mg | Arrêté |
Informations sur le produit
Nom :
rac-Erythro-9-(2-hydroxy-3-nonyl)adenine hydrochloride
Synonymes :
- EHNA hydrochlorideerythro-9-Amino-b-hexyl--a-methyl-9H-purine-9-ethanol hydrochlorideerythro-9-(2-Hydroxy-3-nonyl)-adenine hydroch loride
- (R*,S*)-(+-)-6-Amino-beta-hexyl-alpha-methyl-9H-purine-9-ethanol
- 9H-purine-9-ethanol, 6-amino-beta-hexyl-alpha-methyl-
- 9H-Purine-9-ethanol, 6-amino-beta-hexyl-alpha-methyl-, (R*,S*)-(+-)-
- 3-(6-Amino-9H-purin-9-yl)nonan-2-ol
Description :
Erythro-9-(2-hydroxy-3-nonyl)adenine hydrochloride (EHA) is a molecule that has been shown to inhibit skin tumor formation in mice. It has also been shown to be effective against solid tumours and cancer stem cells in mice. EHA is an amino acid derivative that inhibits the growth of cancer cells by targeting the molecules involved in the formation of skin tumors. The mechanism of action involves the inhibition of protein synthesis and DNA replication, as well as the induction of apoptosis. EHA can be used for pharmaceutical preparations against skin cancer and other solid tumours.
Avis:
Nos produits sont destinés uniquement à un usage en laboratoire. Pour tout autre usage, veuillez nous contacter.
Marque:
Biosynth
Stockage à long terme :
Notes :
Propriétés chimiques
Masse moléculaire :
313.83 g/mol
Formule :
C14H24ClN5O
Degré de pureté :
Min. 95%
MDL:
Point de fusion :
Point d'ébullition :
Point d'éclair :
Densité :
Concentration :
EINECS :
Merck :
Code SH :
